RENAL CELL CARCINOMA (RCC)
Clinical trials for RENAL CELL CARCINOMA (RCC) explained in plain language.
Never miss a new study
Get alerted when new RENAL CELL CARCINOMA (RCC) trials appear
Sign up with your email to follow new studies for RENAL CELL CARCINOMA (RCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Kidney cancer drug combo trial stopped early – what happened?
Disease control TerminatedThis study tested two drugs (toripalimab and lenvatinib) given before and after kidney cancer surgery in people with different stages of kidney cancer. The goal was to see if the treatment could shrink or eliminate the tumor before surgery and keep cancer from coming back after. …
Matched conditions: RENAL CELL CARCINOMA (RCC)
Phase: PHASE2 • Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Can two diabetes drugs save kidneys after cancer surgery?
Disease control TerminatedThis study looked at whether two drugs, finerenone and empagliflozin, can slow kidney function decline in people at high risk for chronic kidney disease after having a kidney removed for cancer. Ten participants took one or both drugs or no drug for a year. The trial was terminat…
Matched conditions: RENAL CELL CARCINOMA (RCC)
Phase: PHASE2 • Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC